Cornercap Investment Counsel’s Emergent Biosolutions EBS Stock Holding History

Cornercap Investment Counsel’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,020	Closed	-$115K	–	245
2024 Q4	$115K	Buy	+12,020	New	+$110K	0.04%	462
2023 Q1	–	Sell	-67,457	Closed	-$797K	–	590
2022 Q4	$797K	Buy	+67,457	New	+$1.04M	0.14%	328
2021 Q3	–	Sell	-19,975	Closed	-$1.26M	–	561
2021 Q2	$1.26M	Buy	19,975 +7,867	+65%	+$505K	0.14%	222
2021 Q1	$1.13M	Buy	+12,108	New	+$1.24M	0.13%	287
2020 Q4	–	Sell	-10,964	Closed	-$1.13M	–	487
2020 Q3	$1.13M	Sell	10,964 -2,368	-18%	-$255K	0.16%	166
2020 Q2	$1.05M	Sell	13,332 -4,666	-26%	-$348K	0.17%	166
2020 Q1	$1.04M	Buy	+17,998	New	+$1.04M	0.2%	139
2019 Q1	–	Sell	-33,115	Closed	-$1.96M	–	417
2018 Q4	$1.96M	Sell	33,115 -6,415	-16%	-$414K	0.3%	104
2018 Q3	$2.6M	Sell	39,530 -1,695	-4%	-$98.9K	0.34%	84
2018 Q2	$2.08M	Sell	41,225 -2,285	-5%	-$119K	0.3%	104
2018 Q1	$2.29M	Sell	43,510 -1,690	-4%	-$84.2K	0.33%	94
2017 Q4	$2.1M	Buy	45,200 +565	+1%	+$23.8K	0.29%	97
2017 Q3	$1.8M	Buy	+44,635	New	+$1.61M	0.25%	109
2016 Q3	–	Sell	-13,025	Closed	-$366K	–	363
2016 Q2	$366K	Buy	+13,025	New	+$511K	0.07%	309

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cornercap Investment Counsel's EBS Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Emergent Biosolutions (EBS) in Q1 2025, closing a stake of 12,020 shares — an estimated $115K sold.

Cornercap Investment Counsel first reported a position in EBS in Q2 2016 and held it in 14 quarters. The position peaked at $2.6M in Q3 2018. 160 funds tracked by Wall St. Rank hold EBS as of Q1 2025.

Cornercap Investment Counsel reported no remaining Emergent Biosolutions position as of Q1 2025 after selling out during the quarter.
Cornercap Investment Counsel sold 12,020 Emergent Biosolutions shares in Q1 2025, an estimated $115K.
Cornercap Investment Counsel first reported a position in Emergent Biosolutions in Q2 2016 and held it in 14 quarters.
Cornercap Investment Counsel's Emergent Biosolutions position peaked at $2.6M in Q3 2018.
160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.